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Abstract
Methods for the formation of supported lipid monolayers on top of a hydrophobic self assembled monolayer in a surface
plasmon resonance instrument are described. Small unilamellar vesicles absorb spontaneously to the surface of the
hydrophobic self-assembled monolayer to form a surface which resembles the surface of a cellular membrane. Lipophilic
ligands, such as small acylated peptides or glycosylphosphatidylinositol-anchored proteins, were inserted into the absorbed
lipid and binding of analytes to these ligands was analysed by surface plasmon resonance. Conditions for the formation of
lipid monolayers have been optimised with respect to lipid type, chemical and buffer compatibility, ligand stability and
reproducibility. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Many of the interactions studied in the biological
and biomedical sciences occur at membrane surfaces.
There are, however, very few methods that allow
quantitative determination of such interactions.
Most techniques for detailed analysis of molecular
recognition events are applied in solution phase using
a soluble form of the receptor. Membrane receptors
typically possess hydrophobic domains and are likely
to have di¡erent tertiary structures and binding af-
¢nities in solution relative to those occurring in a
membrane environment. Therefore, the need exists
for a technique that allows the analysis of mem-
brane-associated receptor^analyte interactions in
their native environment. Supported lipid mono-
layers can be formed on an alkane-thiol self-as-
sembled monolayer, which is in turn mounted on a
gold surface [1]. The lipid monolayer formed in this
0005-2736 / 98 / $19.00 ß 1998 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 9 8 ) 0 0 0 9 1 - 1
Abbreviations: SPR, surface plasmon resonance; RU, re-
sponse units; HPA chip, hydrophobic association sensor chip;
CAPS, 3-[cyclohexylamino]-1-propanesulphonic acid; HBTU, 2-
(1H-benzotriazole-1-yl)-1,1,3,3-tetramethylammonium hexa£uo-
rophosphate; SUV, small unilamellar vesicle ; SDS, sodium
dodecylsulphate; BSA, bovine serum albumin; APN, amino-
peptidase N; GPI, glycosylphosphatidylinositol ; PC, L-K-phos-
phatidylcholine; DMPC, dimyristoylphosphatidylcholine;
DPPC, dipalmitoylphosphatidylcholine; DSPC, distearoylphos-
phatidylcholine; DAPC, diarachidonylphosphatidylcholine;
POPC, palmitoyloleoylphosphatidylcholine; MIC, minimum in-
hibitory concentration; Gal-NAc, N-acetyl galactosamine
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way provides a chemically and physically stable en-
vironment which resembles the surface of a cellular
membrane, and the gold surface is suitable for sur-
face plasmon resonance (SPR) analysis. Changes in
the measured refractive index at the interface, given
in response units, are proportional to the amount of
material in the immediate vicinity of the sensor sur-
face [2]. Bu¡ered solutions of an analyte are passed
over the surface and the a⁄nity of the binding event
can be calculated from analysis of the resultant bind-
ing curve.
Following the pioneering work of Vogel and co-
workers [1], several applications exploiting this tech-
nology have been reported [3^5]. Whilst the analysis
of receptor^analyte interactions in a membrane-like
environment is now technically possible, there are no
guidelines for experimental design published in the
literature. This study redresses the relative paucity
of information on the above model membrane sys-
tem and demonstrates the utility of supported lipid
monolayers in the analysis of two di¡erent mem-
brane-associated interactions. A general methodol-
ogy for formation of supported lipid monolayers
containing lipophilic ligands is described and condi-
tions have been optimised with respect to lipid type,
chemical and bu¡er compatibility, ligand stability
and reproducibility.
2. Materials and methods
Octyl D-glucoside, bovine serum albumin, L-K-
phosphatidylcholine, dimyristoylphosphatidylcho-
line, dipalmitoylphosphatidylcholine, distearoylphos-
phatidylcholine and diarachidonylphosphatidylcho-
line were purchased from Sigma-Aldrich (UK).
[3H]dipalmitoylphosphatidylcholine was obtained
from Amersham, UK. Disialylganglioside GD1a
was purchased from Matreya, (Pleasant Gap, PA).
The isolation, puri¢cation and preparation of the
insecticidal Cry toxin and its receptor, APN, has
been described in detail elsewhere [6,7]. The synthesis
of the acylated mucopeptide analogue N-K-docosa-
noyl-N-O-acetyl-lysyl-D-alanyl-D-alanine used for the
antibiotic binding experiments has been described
previously [8]. The glycopeptide antibiotics biphenyl-
chloroeremomycin (LY307599), chloroeremomycin
(LY264826), eremomycin and vancomycin were a
gift from Eli Lilly (Indianapolis, IN) Teicoplanin
and teicoplanin aglycone A3-1 were a gift from
MMDR1 Lepetit Research Centre (Gerenzano,
Italy). Ristocetin A was obtained from Abbot Labo-
ratories (North Chicago, IL). The SPR instrument
was a BIACORE 2000 (Biacore, UK) used with a
hydrophobic association (HPA) chip which consisted
of an octadecane-thiol self assembled monolayer on a
gold surface. Each sensor chip contained four £ow
cells of dimensions 2.4U0.5U0.05 mm (lUwUh)
with a probing spot for the SPR signal of ca. 0.26
mm2 for each £ow cell.
2.1. Preparation of vesicles
2.1.1. Extrusion
Small unilamellar vesicles (SUV) were prepared [9]
in phosphate bu¡er (100 mM Na2HPO4/NaH2PO4,
pH 7.4) by extrusion. Typical procedure: egg yolk L-
K-phosphatidylcholine (128 mg, 0.16 mmol) was dis-
solved in ethanol free chloroform (10 ml) in a 100 ml
round bottom £ask. The lipid was deposited as a thin
¢lm by removal of the solvent under reduced pres-
sure on a rotary evaporator, then dried under high
vacuum for 2 h. Phosphate bu¡er (8 ml) was then
added to give a 20 mM suspension. The lipid was
shaken for 30 min, sonicated in a bath sonicator
for 2 min, then passed 17 times through a 50-nm
polycarbonate ¢lter in an Avestin Lipofast Basic ex-
trusion apparatus to give a translucent solution.
2.1.2. Sonication
Vesicles were formed as a suspension in phosphate
bu¡er as described above, then subjected to probe
sonication in a MSE Soniprep 150 (3U10 min at
6 Wm amplitude using a 3 mm microtip probe) and
puri¢ed by ultracentrifugation [10].
2.2. Formation of lipid monolayers
The surface of an HPA sensor chip was cleaned by
a 10 min injection of 40 mM octyl D-glucoside at a
£ow rate of 10 Wl/min. The injection needle was
cleaned by pre-dipping in water, then SUV (20 Wl,
500 WM) injected immediately at a £ow rate of 2 Wl/
min. The lipid layer was then washed at 100 Wl/min
with sodium hydroxide (10 mM, 20 Wl). The degree
of coverage of the surface was determined from the
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amount of lipid bound at a stable level (after the
sodium hydroxide wash) and from the extent of
non-speci¢c binding of BSA (0.1 mg/ml in phosphate
bu¡er, 5 min injection). The usable lifetime of the
sensor chip was assayed by repeated cycles of loading
with egg PC SUV and cleaning with octyl D-gluco-
side as described above.
2.3. Measurement of lipid surface concentration
A mixture of [1H]DPPC (2 mg in chloroform) and
[3H]DPPC (0.1 ml of a 110 WCi/ml solution in
chloroform/toluene) was shaken at 50‡C for 30
min, then deposited on the walls of a 100 ml round
bottom £ask by removal of solvent on a rotary evap-
orator. Small unilamellar vesicles were then formed
in phosphate bu¡er by sonication, as described
above. All four £ow cells of a new HPA sensor
chip were loaded with these vesicles (30 Wl, 2 Wl/
min, 2 mM DPPC) at 40‡C using phosphate bu¡er
as the eluent, as described above. Following forma-
tion of a stable signal after loading with vesicles,
octyl D-glucoside (75 Wl, 15 Wl/min, 40 mM) was in-
jected across the surface and the elute collected for
analysis. The process of loading with lipid and wash-
ing with detergent was repeated 20 times and all
recovered fractions pooled. Octyl D-glucoside (1 ml,
40 mM) was added to the original [3H]DPPC vesicle
preparation (1 ml, 2 mM DPPC) to dissolve the lipid
and then this sample and the pooled lipid-detergent
fractions recovered from the sensor chip were diluted
in Optiphase ‘Hisafe 3’ scintillation £uid (Fischer
Scienti¢c, UK) (10 ml). L-Radiation of the samples
were measured using a TriCarb 2200 CA liquid scin-
tillation analyser calibrated with an internal reference
sample (Packard 3H 253200 DPM). Scintillation
counts were performed 10 times.
2.4. Preparation of t-Boc-D-Q-glutamyl(K-benzyl)-
lysyl(N-O-acetyl)-D-alanyl-D-alanine benzyl ester
t-Boc-N-O-acetyl-lysyl-D-alanyl-D-alanine benzyl es-
ter [8] (1.19 g, 2.29 mmol) was dissolved in dichloro-
methane (25 ml) and a solution of hydrochloric acid
in dioxane (4 M, 8 ml) and the resulting mixture was
allowed to stir for 2 h. The solvent was then removed
and the last traces of hydrogen chloride were re-
moved by the successive addition and evaporation
of dichloromethane (3U20 ml). A solution of t-
Boc-glutamic acid-K-benzyl ester (850 mg, 2.50
mmol), N,N-diisopropylethylamine (350 mg, 2.71
mmol) and HBTU (1.04 g, 2.74 mmol) in dichloro-
methane (20 ml) was stirred for 10 min and to this
was added the crude N-O-acetyl-lysyl-D-alanyl-D-ala-
nine benzyl ester hydrochloride and N,N-diisoprop-
ylethylamine (820 mg, 6.34 mmol) in dichlorome-
thane (30 ml). The resulting solution was stirred at
room temperature for 4 h and the solvent removed.
The residue obtained was chromatographed over sili-
ca (chloroform initially, then methanol/chloroform,
1:9) and the major band collected and evaporated
to dryness to a¡ord t-Boc-D-Q-glutamyl(K-benzyl)-ly-
syl(N-O-acetyl)-D-alanyl-D-alanyl benzyl ester (1.54 g,
91%) as a white solid. 1H-NMR (500 MHz; DMSO-
d6) N 1.12^1.37 (19 H, m, 2UAla CH3, Boc CH3, Lys
N and Lys Q), 1.40^1.50 (1 H, m, Lys L), 1.51^1.59 (1
H, m, Lys L), 1.69^1.77 (4 H, m, acetyl CH3 and Glu
L), 1.85^1.94 (1 H, m, Glu L), 2.10^2.27 (2 H, m, Glu
Q), 2.95 (2 H, app q, Lys O), 3.94^4.00 (1 H, m, Glu
K), 4.11^4.18 (1 H, m, Lys K), 4.24^4.33 (2 H, m,
2UAla K), 5.04^5.12 (4 H, m, 2Ubenzylic CH2), 7.25
(1 H, d, J 7.6 Hz, Glu NH), 7.27^7.37 (10 H, m, aryl
H), 7.68^7.76 (1 H, m, acetyl NH), 7.94 (1 H, d, J 7.4
Hz, Lys NH), 8.11 (1 H, d, J 7.8 Hz, Ala NH), 8.23
(1 H, d, J 6.9 Hz, Ala NH).
2.5. Preparation of N-docosanoyl-D-Q-glutamyl
(K-benzyl)-lysyl(N-O-acetyl)-D-alanyl-D-alanine
benzyl ester
N-t-Boc-D-Q-glutamyl(K-benzyl)-lysyl(N-O-acetyl)-
D-alanyl-D-alanyl benzyl ester [8] (100 mg, 0.14
mmol) was dissolved in a mixture of dichlorometh-
ane (2 ml) and a solution of hydrochloric acid in
dioxane (4 M, 4 ml) and stirred for 2 h. The solvent
was then removed and the last traces of hydrogen
chloride were removed by the successive addition
and evaporation of dichloromethane (3U5 ml). A
mixture of docosanoic acid (50 mg, 0.15 mmol),
N,N-diisopropylethylamine (90 mg, 0.70 mmol) and
HBTU (62 mg, 0.17 mmol) in dichloromethane (2 ml)
and methanol (2 ml) was stirred for 10 min and to
this was added the crude D-Q-glutamyl(K-benzyl)-ly-
syl(N-O-acetyl)-D-alanyl-D-alanine benzyl ester hydro-
chloride and N,N-diisopropylethylamine (90 mg, 0.70
mmol) in dichloromethane (2 ml). The resulting sol-
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ution was stirred at room temperature for 4 h and
the solvent was removed. The residue obtained was
then chromatographed over silica (chloroform ini-
tially, then methanol/chloroform, 2:98 through to
8:92). The major band was collected and evaporated
to dryness to a¡ord N-docosanoyl-D-Q-glutamyl(K-
benzyl)-lysyl(N-O-acetyl)-D-alanyl-D-alanine benzyl
ester (85 mg, 87%) as a white solid. 1H-NMR (500
MHz; DMSO-d6) N 0.83 (3 H, t, J 7.0 Hz, docos
CH3), 1.14 (3 H, d, J 7.1 Hz, Ala CH3), 1.17^1.38
(43 H, m, 18Udocos CH2, Lys Q, Ala CH3 and Lys
N), 1.40^1.51 (3 H, m, docos L and Lys L), 1.52^1.60
(1 H, m, Lys L), 1.71^1.82 (4 H, m, acetyl CH3 and
Glu L), 1.88^1.96 (1 H, m, Glu L), 2.08 (2 H, t, J 7.3
Hz, docos K), 2.13^2.21 (2 H, m, Glu Q), 2.96 (2 H,
app q, Lys O), 4.11^4.18 (1 H, m, Lys K), 4.20^4.31 (3
H, m, Glu K and 2UAla K), 5.05^5.11 (4 H, m,
2Ubenzylic CH2), 7.27^7.37 (10 H, m, aryl H),
7.69^7.74 (1 H, m, acetyl NH), 7.95 (1 H, d, J 7.5
Hz, Lys NH), 8.11 (1 H, d, J 7.9 Hz, Ala NH), 8.17
(1 H, d, J 7.4 Hz, Glu NH), 8.03 (1 H, d, J 7.0 Hz,
Ala NH).
2.6. Preparation of N-docosanoyl-D-Q-glutamyl-
lysyl(N-O-acetyl)-D-alanyl-D-alanine
(N-docosanoyl-EKAA)
N-docosanoyl-D-Q-glutamyl(K-benzyl)-lysyl(N-O-ac-
etyl)-D-alanyl-D-alanine benzyl ester [8] (80 mg, 0.08
mmol) was dissolved in a mixture of absolute ethanol
(65 ml), dichloromethane (15 ml) and toluene (10 ml)
and hydrogenated for 12 h at 1 atm over 5% palladium
on charcoal (15 mg). The reaction mixture was then
¢ltered through celite and evaporated to dryness to
a¡ord N-docosanoyl-D-Q-glutamyl-lysyl(N-O-acetyl)-
D-alanyl-D-alanine (57 mg, 87%) as a white solid. 1H-
NMR (500 MHz; DMSO-d6) N 0.84 (3 H, t, J 7.1 Hz,
docos CH3), 1.14^1.28 (44 H, m, 18Udocosanyl CH2,
Lys Q and 2UAla CH3), 1.30^1.38 (2 H, m, Lys N),
1.42^1.51 (3 H, m, docos L and Lys L), 1.52^1.62 (1
H, m, Lys L), 1.64^1.73 (1 H, m, Glu L), 1.75 (3 H, m,
acetyl CH3), 1.88^1.98 (1 H, m, Glu L), 2.09 (2 H, t, J
7.4 Hz, docos K), 2.16 (2 H, t, J 7.5 Hz, Glu Q), 2.96 (2
H, app q, Lys O), 4.04^4.16 (3 H, m, Lys K, Glu K and
Ala K), 4.23 (1 H, app quin, Ala K), 7.73^7.78 (1 H, m,
acetyl NH), 7.92 (1 H, d, J 7.2 Hz, amide NH), 7.95 (1
H, d, J 7.4 Hz, amide NH), 8.02 (1 H, d, J 7.5 Hz,
amide NH), 8.14 (1 H, d, J 7.2 Hz, Ala NH).
2.7. Deposition of ligands
Small acylated ligands (6 1000 Da) were inserted
directly into a lipid monolayer by injection of dilute
solutions (ca. 50 WM) across the monolayer at a £ow
rate of 10 Wl/min. Larger molecules, such as the GPI
anchored protein APN [11], did not associate at sta-
ble levels with a pre-formed lipid monolayer when
injected across the surface as dilute solutions. Depo-
sition of the GPI anchored protein APN was
achieved by loading the sensor chip with protein-con-
taining small unilamellar vesicles formed by shaking
puri¢ed APN (100 nM) for 5 min with vesicles
formed by extrusion of PC (500 WM) in phosphate
bu¡er. The control surface (usually lipid alone) was
always in the ¢rst £ow cell of the SPR instrument to
prevent contamination from other £ow cells contain-
ing ligand.
2.8. Stability of the lipid monolayer
Lipid monolayers formed as described above were
exposed to a number of reagents that disrupt ligand^
ligate complexes. The following reagents were injected
across the surface for 2 min at a £ow rate of 20 Wl/min:
10% ethanol/water, 10% dimethylsulphoxide/water,
10% ethanolamine/water, 2 M sodium chloride, 2 M
potassium chloride, 10 mM glycine (pH 2), 10 mM
sodium carbonate, 100 mM cysteine hydrochloride
and 100 mM hydrochloric acid. The stability of the
lipid layer following exposure to the above reagents
was assayed by £owing phosphate bu¡er at a rate of 10
Wl/min across the surface for 18 h.
2.9. Cry1Ac puri¢cation and activation
Bacillus thuringiensis subsp. kurstaki HD73 ex-
pressing the Cry1Ac toxin was grown as described
for Bacillus megaterium KM [12]. The Cry1Ac crystal
inclusions were puri¢ed from sporulated B. thurin-
giensis cultures using discontinuous sucrose gradients
[6] and the protein concentration was determined by
the method of Lowry et al. [13] using BSA as a
standard. Solubilisation of the Cry1Ac crystal in 50
mM Na2CO3/HCl, pH 9.5, plus 10 mM DTT, acti-
vation with Pieris brassicae gut extract and SDS-
PAGE analysis were carried out as described previ-
ously [6].
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2.10. Cry toxin binding assay
Activated Cry1Ac toxin was separated from small
molecular mass digest products using a Micro Bio-
spin 30 chromatography column (Bio-Rad) following
the manufacturer’s instructions. This step also ex-
changed the toxin incubation bu¡er with CAPS buf-
fered saline (10 mM CAPS, KOH, 150 mM NaCl,
pH 10). Quanti¢cation of the activated toxin prepa-
rations was carried out from UV absorbance at 280
nm and corrected using control enzyme preparations.
Toxin was diluted in CAPS bu¡ered saline from 500
to 16 nM and was passed serially at a £ow rate of 20
Wl/min over a £ow cell containing lipid alone, then
over a £ow cell containing lipid and APN receptor.
The sample solution was then replaced by bu¡er and
the toxin^receptor complex allowed to dissociate for
4 min. The stability of the toxin^receptor complex
was then assayed by 20 Wl injections of 10 mM
NaOH, 10 mM HCl, 1 M KCl and 100 mM Gal-
NAc. All assays were carried out at 25‡C. Data were
prepared for analysis by subtracting the average re-
sponse recorded 20 s prior to injection and adjusting
the time of each injection to zero. Data from the £ow
cell containing lipid alone was then subtracted from
corresponding data obtained from the receptor-con-
taining £ow cell to correct for bulk refractive index
changes. Analysis was carried out using BIAevalua-
tion 3.0 global analysis software based on algorithms
for numerical integration [14].
2.11. Antibiotic binding assay
Glycopeptide antibiotics were diluted serially in
phosphate bu¡er (100 mM, pH 7.4) from 4 to 0.63
WM and were passed sequentially over a control £ow
cell containing a lipid monolayer alone, then over a
£ow cell containing lipid and 200 response units
(RU) of N-docosanoyl-L-Lys(Ac)-D-Ala-D-Ala [8] at
a £ow rate of 20 Wl/min. The sample solution was
then replaced by phosphate bu¡er and the analyte^
receptor complex allowed to dissociate. Regeneration
of the free ligand was e¡ected by a 1 min injection of
10 mM hydrochloric acid. Five dummy runs of bind-
ing and regeneration were performed before data ac-
quisition. All assays were carried out at 25‡C. Data
were prepared and analysed as described above for
the toxin binding assay.
2.12. Data analysis
Analysis was carried out by non-linear ¢tting of
data corrected for bulk refractive index changes as
described above using BIAeval 3.0 global analysis
software based on algorithms for numerical integra-
tion [14,15].
For the simple bimolecular association, A+B = AB,
the process was assumed to be pseudo ¢rst order
with no interaction between separate receptor mole-
cules. The dissociation rate is derived from the equa-
tion:
Rt  Rt0 e3kdt3t0 1
where Rt is the response at time t, Rt0 is the response
at time t0 and kd is the dissociation rate constant.
The association rate constant can be derived using
the equation:
Rt  kaCRmax13e
3kaCkdt
kaC  kd 2
where Rmax is the maximum response (proportional
to the amount of immobilised ligand), C is the con-
centration of analyte in solution, and ka is the asso-
ciation rate constant.
A⁄nities were calculated from the ratio of ka/kd
and also from analysis of equilibrium binding levels
at varying analyte concentration. By measuring the
resonance units attained at equilibrium as a function
of analyte concentration, a⁄nities can be determined
from a Scatchard analysis using the equation:
Req
C
 KaRmax3KaReq 3
where Req is the response at equilibrium and Ka is
the association constant. A plot of Req/C versus C
has a slope of 3Ka.
3. Results and discussion
3.1. Formation of lipid monolayers
Lipid monolayers were formed on the HPA chip
using small unilamellar vesicles prepared from phos-
phatidylcholine (PC) by probe sonication, and also
by extrusion. The propensity for the di¡erent vesicle
preparations to form stable monolayers on the sen-
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sor chip was assayed by examining the amount of
lipid deposited, and the extent of non-speci¢c bind-
ing of BSA, which binds signi¢cantly to the sensor
chip in the absence of lipid (data not shown). Opti-
mal coverage of the sensor chip in all cases was ob-
tained when vesicles were injected over the surface at
low £ow rate immediately following a cleansing pulse
of octyl D-glucoside. This resulted in an unstable sig-
nal ca. 4000 RU above the original level, possibly
due to multilamellar structures on the sensor chip.
Washing the surface with base resulted in a stable
signal of ca. 2200 RU (Fig. 1). There was little di¡er-
ence in the degree of coverage of the sensor chip
between vesicles formed by sonication or by extru-
sion and between injections of a low concentration of
vesicles over several hours or a single injection at
higher concentration (Table 1).
The SPR response was correlated with surface
concentration on the HPA sensor chip using 3H-la-
belled dipalmitoylphosphatidylcholine ([3H]DPPC).
Vesicles containing [3H]DPPC were loaded onto a
sensor chip and the lipid layer was then washed o¡
with detergent. Scintillation counts of lipid-contain-
ing fractions recovered from the sensor chip showed
good reproducibility with a relative standard devia-
tion of less than 0.5%. Comparison of the average
scintillation count in the recovered fractions with
that obtained for the [3H]DPPC vesicle preparation
used to form the lipid layers enabled determination
of the total amount of lipid absorbed on the sensor
chip. The correlation with response units was
0.92 þ 0.05 pg mm32 RU31, an identical value to
that reported [2] for absorption of 35S- and 14C-la-
belled proteins onto a dextran hydrogel-derivatised
CM5 sensor chip. 2200 RU of PC loaded on an
HPA chip of area 1.2 mm2 thus corresponds to a
surface lipid density of 2.0 ng mm32 or 2.6 pmol
mm32, and an area per lipid molecule of 64 Aî 2.
The calculated surface density is approximately half
that reported [16] for a supported lipid bilayer (5.5
pmol mm32) and the calculated lipid head group
area agrees well with the value determined [17] for
hydrated DPPC by continuous X-ray scattering (66
Aî 2). The surface capacity of the HPA sensor chip is
lower than that of the CM5 chip (50 ng mm32) as the
HPA surface is planar, whereas the CM5 surface is
coated with a ca. 200 nm thick hydrogel [2].
The degree of non-speci¢c binding of BSA to the
sensor chip increased upon repeated cycles of loading
with lipid and cleaning with detergent (Fig. 2). For
the ¢rst 10 cycles of loading and cleaning, the
amount of lipid bound to the surface decreased,
but the surface remained biospeci¢c. After ten cycles,
a dramatic jump in the amount of non-speci¢c bind-
ing of BSA occurred. There was signi¢cant variation
Fig. 1. Formation of a lipid monolayer with small unilamellar
phosphatidylcholine vesicles. Formation of a stable lipid mono-
layer by successive injections of octyl-D-glucoside (40 mM),
small unilamellar phosphatidylcholine vesicles (50 nm, 500 WM),
sodium hydroxide (10 mM), then BSA (0.1 mg/ml) over an
HPA sensor chip using phosphate bu¡er as eluent. Arrows indi-
cate the beginning and end of each injection.
Table 1
Formation of lipid monolayers on an HPA sensor chip with small unilamellar phosphatidylcholine vesicles formed by extrusion, and
by sonication
SUV injected (no. of injectionsUconcentration) Initial loadinga Loading after NaOH washa BSA bounda;b
Extruded 1U500 WM 4600 (240) 2390 (190) 30 (4)
Extruded 5U100 WM 4880 (210) 2430 (120) 0 (0)
Sonicated 1U500 WM 2740 (170) 2010 (100) 40 (7)
Sonicated 5U100 WM 3770 (190) 2350 (170) 10 (2)
aValues given as response units with standard deviations in brackets for n = 3.
bUbiquitin gave nearly identical values to BSA.
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in the usable lifetime of sensor chips from di¡erent
manufactured batches. Attempts to regenerate the
surface of an e¡ete sensor chip with Triton X-100
or sodium dodecylsulphate (SDS) were unsuccessful.
Vesicles were successfully loaded onto the sensor
chip in a number of common biological bu¡ers, but
not in low ionic strength bu¡er (Table 2). Compar-
ison of lipid loaded in 10 mM Tris-EDTA (TE) and
100 mM NaCl-Tris-EDTA (STE) shows that the cov-
erage of the sensor chip with lipid, as indicated by
the amount of non-speci¢c binding of BSA, was
much less for TE than for STE (Table 2). PC mono-
layers were stable with many reagents (described in
Section 2) used for regeneration of free ligand from
bound analyte. The amount of lipid deposited on the
surface of the sensor chip was stable following expo-
sure to these reagents, as the response level did not
change more than the level of intrinsic drift of the
instrument ( þ 0.3 RU/min).
3.2. Ligand stability and lipid type
Stable immobilised ligand levels are of paramount
importance for SPR analysis. This is especially perti-
nent when using the HPA sensor chip, as the immo-
bilised ligand is not covalently attached to the sur-
face, but held in place by hydrophobic interactions.
It should be noted that prevention of dissociation of
the ligand from the monolayer is of primary impor-
tance for experimental design, because if the dissoci-
ation rate of the analyte^ligand complex is compara-
ble to the dissociation rate of the ligand from the
lipid monolayer, spurious results will be obtained.
It was found that acylated small molecules were
best deposited on the chip by injection as dilute sol-
utions over a pre-formed lipid monolayer. The
amount of ligand inserted, measured in response
units (RU), was directly proportional to the injection
time, up to a level of ca. 2000 RU (data not shown).
Membrane-associated proteins were best deposited
on the chip together with lipid from protein-contain-
ing small unilamellar vesicles which were formed by
extrusion.
A number of amphipathic molecules were assayed
for their a⁄nity for a PC lipid monolayer. The mu-
copeptide bacterial cell wall analogue N-K-decanoyl-
Fig. 2. Repeated loading of an HPA sensor chip with phospha-
tidylcholine vesicles. Amount of lipid initially bound (8),
bound after sodium hydroxide wash (O), and amount of BSA
bound (a), to an HPA sensor chip upon repeated loading of
phosphatidylcholine small unilamellar vesicles as described in
Section 2.
Table 2
Loading of an HPA sensor chip with PC SUV (50 nm, 500 WM) in di¡erent bu¡ers
Bu¡er pH of bu¡er Initial loadingg Loading after NaOH washg BSA boundg
Phosphatea 7.4 4 600 (240) 2 390 (190) 30 (4)
Citrateb 5.0 11 100 (1100) 2 120 (210) 20 (6)
10 mM TEc 8.0 1 960 (160) 1 780 (140) 900 (110)
100 mM STEd 8.0 4 560 (250) 2 060 (120) 10 (4)
HEPESe 8.0 4 610 (270) 2 100 (140) 70 (5)
CAPSf 10.0 2 200 (180) 2 020 (160) 60 (5)
a100 mM Na2HPO4/NaH2PO4.
b100 mM sodium citrate/NaH2PO4.
cTris-HCl 10 mM, EDTA 1 mM.
dTris-HCl 10 mM, EDTA 1 mM, NaCl 100 mM.
e10 mM N-(2-hydroxyethyl) 1-piperazine-NP-(2-ethanesulphonic acid), 100 mM NaCl.
f 10 mM 3-cyclohexylamino-1-propane sulphonate, 150 mM NaCl.
gValues given as response units with standard deviations for n = 3.
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L-Lys(Ac)-D-Ala-D-Ala, which possesses a C10 lipo-
philic anchor, showed relatively low a⁄nity for a
PC monolayer (Ka = 4.3U103 M31). This value is
comparable with the value (Ka = 3.4U103 M31) cal-
culated for the association of a similar peptide (N-K-
decanoyl-Gly-Ala-Ala) with PC vesicles, determined
by electrophoretic mobility and equilibrium dialysis
measurements [18]. Peptides with a hydrophobic an-
chor possessing low a⁄nity for the lipid layer may
not, therefore, remain immobilised in the lipid upon
binding to an analyte where the e¡ect of the analyte
is to increase the aqueous solubility of the peptide.
N-Docosanoyl-L-Lys(Ac)-D-Ala-D-Ala, which pos-
sesses a C22 lipophilic anchor, showed a much higher
a⁄nity for the monolayer (Ka = 8.3U106 M31) and
was used in subsequent glycopeptide antibiotic bind-
ing experiments. The disialyganglioside, GD1a,
bound to lipid with a very high a⁄nity
(Ka = 7U109 M31), with a dissociation rate constant
below the limits of detection of the SPR instrument
(i.e. kd6 1035 s31). Aminopeptidase N (APN) [11] a
glycosylphosphatidylinositol-anchored protein also
possessed a high a⁄nity (Ka = 1.9U108 M31) for
the PC monolayer.
The amphipathic peptide N-docosanoyl-D-Q-Glu-L-
Lys(Ac)-D-Ala-D-Ala N-docosanoyl-EKAA was used
as a probe to determine the e⁄cacy of di¡erent lipid
types to anchor small ligands with hydrophobic tails.
Lipid monolayers were formed from lipids with vary-
ing acyl chain length and possessing di¡erent transi-
tion temperatures from the gel-like to the liquid crys-
tal-like state [19]. The results show that binding of N-
docosanoyl-EKAA to these lipid monolayers did not
vary signi¢cantly between di¡erent lipid types (Fig.
3). Lipid monolayers were best formed when the lipid
was used above its phase transition temperature and
in a liquid crystal-like state. At 25‡C, egg yolk PC,
DMPC and unsaturated lipids, such as POPC,
should result in a £uid monolayer [19].
3.3. Toxin binding to a GPI anchored membrane
receptor
Post-translationally added glycoinositol phospho-
lipids serve as membrane anchors for a wide variety
of outer membrane proteins. By substituting the 3P-
mRNA end sequence which codes for naturally oc-
curring GPI-anchored proteins (i.e. that sequence
which directs GPI anchoring) for endogenous 3P-
mRNA, virtually any protein can be expressed as a
GPI anchored derivative [20]. Aminopeptidase N
(APN) is a well characterised GPI anchored protein
that acts as a receptor for the N-endotoxin Cry1Ac, a
bacterial toxin isolated from B. thuringiensis which
possesses potent insecticidal activity [7,11]. The toxin
is initially translated as an inactive protoxin which is
cleaved and activated by proteases in the midgut of
the insect. It is thought to undergo a conformational
change upon binding to APN which results in toxin
pore formation in the epithelial cell membrane of the
insect midgut [21].
Puri¢ed APN receptor was deposited on the sensor
chip together with lipid using extruded PC vesicles
shaken in an aqueous suspension of the receptor.
Binding studies were carried out in CAPS bu¡ered
saline at pH 10.0, conditions approximating the al-
kaline conditions in the target lepidopeteran insect
gut [21]. At least some of the receptor appeared to
be correctly inserted on the surface of the monolayer
as speci¢c binding of activated Cry1Ac to the APN-
lipid monolayer compared to the lipid monolayer
alone was observed (Fig. 4). Cry1Ac bound to the
receptor in a biphasic manner; the initial association
was very fast (t = 0^10 s), followed by a slower step
Fig. 3. Injection of the amphipathic peptide N-docosanoyl-
EKAA across lipid monolayers composed of di¡erent types of
lipid. Lipid monolayers were formed in phosphate bu¡er as de-
scribed in Section 2 from small unilamellar vesicles composed
of DMPC (U), DPPC (b), DSPC (8), DAPC (+) and PC (a).
Their ability to anchor the amphipathic peptide N-docosanoyl-
EKAA was then assayed by injections of the peptide (30 Wl, 20
WM) at a £ow rate of 10 Wl/min across the di¡erent mono-
layers.
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(t = 20^180 s) (Fig. 4). After an initial fast dissocia-
tion, the SPR signal did not return to original base-
line levels, but remained stable at a higher level. Tox-
in thus associated with the monolayer could not be
removed with reagents (described in Section 2) that
normally disrupt weak interactions, or by 100 mM
N-acetylgalactosamine, which has been shown to
completely inhibit binding of the toxin to the recep-
tor upon pre-incubation with toxin [22]. It is highly
likely that in the stable complex, the toxin is em-
bedded in the lipid monolayer and hence resistant
to dissociation by reagents in the aqueous phase.
The toxin thus appears to bind rapidly to the recep-
tor, then there is a slow step which is believed to be
associated with insertion of the toxin into the lipid
monolayer.
The calculated a⁄nity of the toxin for the APN-
lipid monolayer was 3.0 nM, which approaches the
a⁄nity range, 0.2^1.6 nM, previously reported for
radiolabelled Cry1Ac toxin interactions with receptor
containing vesicles [23,24]. An a⁄nity of 95 nM was
reported [22] for the Cry1Ac interaction with solubi-
lised APN immobilised on a dextran matrix sensor
chip in the absence of other membrane components.
This is much lower than the a⁄nity range noted
above for the radiolabelled binding studies and sug-
gests that this value is only a measure of the initial
binding event.
3.4. Glycopeptide antibiotic binding to bacterial
mucopeptide analogues
The emergence of vancomycin-resistant enterococ-
ci (VRE) and the accompanying increase in the num-
ber of deaths from bacterial infections has given new
urgency to studies of the clinically important glyco-
peptide antibiotics. We have shown previously that
glycopeptide antibiotics dimerise in aqueous solution
[25] and that antibiotics with high dimerisation con-
stants are generally potent inhibitors of bacterial
growth [26]. We have proposed that the glycopeptide
antibiotics are able to bind co-operatively as dimers
Fig. 4. Binding of Cry1Ac toxin and proteases to an APN-lipid
monolayer. Injections of activated Cry1Ac toxin at 125 nM (a)
and gut extract proteases control (U) over an APN-lipid mono-
layer. There was no binding of proteases used to activate the
toxin. There was no binding of activated Cry1Ac toxin to the
control surface composed of lipid alone (b). The data for bind-
ing of Cry1Ac to the APN-lipid monolayer has been corrected
for bulk refractive index changes by subtraction of data for
binding to the control surface consisting of lipid alone. No
such correction has been made to the controls.
Fig. 5. Supported lipid monolayer model of glycopeptide antibiotic binding. (a) Disruption of peptidoglycan synthesis by binding of
an antibiotic dimer to nascent mucopeptide terminating in the sequence L-Lys-D-Ala-D-Ala. (b) Supported lipid monolayer model of a
bacterial membrane with antibiotic dimer binding to lipoylated peptide terminating in the sequence L-Lys-D-Ala-D-Ala.
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to two nascent mucopeptides at the bacterial mem-
brane surface, thereby disrupting cell wall synthesis
(Fig. 5a). The target mucopeptide precursors termi-
nate in the sequence L-Lys-D-Ala-D-Ala [27]. Peptides
of varying length terminating in this sequence have
been linked via their N-termini to a lipophilic anchor
[8] for insertion in a supported lipid monolayer. This
has allowed analysis of glycopeptide antibiotic activ-
ity at a model membrane surface (Fig. 5b).
The glycopeptide antibiotic chloroeremomycin
bound to the amphipathic mucopeptide analogue
N-docosanoyl-L-Lys(Ac)-D-Ala-D-Ala to reproduci-
ble response levels for up to 40 cycles of binding
and regeneration (Fig. 6). The observed association
rate of the antibiotics did not vary signi¢cantly when
the £ow rate was increased from 20 to 80 Wl/min
indicating the interaction was not mass transport
limited [28].
A⁄nity constants of antibiotics for the mucopep-
tide analogue, calculated by Scatchard analysis of the
steady state response attained at varying concentra-
tion, showed a correlation with observed antimicro-
bial activity in vitro (Fig. 7). In contrast, binding
a⁄nities calculated [26] for antibiotics with peptide
in free solution showed no correlation with antimi-
crobial activity [4]. The a⁄nities of the strongly di-
merising antibiotics for peptide anchored in the lipid
monolayer are higher than those for peptide meas-
ured in free solution. In conjunction with other evi-
dence [26,29] this result suggests that at the surface
the antibiotic dimer can bind co-operatively to two
peptides (Fig. 5b). Those antibiotics with high dimer-
isation constants and those possessing lipophilic
membrane anchors showed the highest a⁄nity for
peptide [4]. These two locating devices are thought
to be crucial for activity against VRE [30].
4. Conclusions
The HPA sensor chip employed in an SPR instru-
ment enables kinetic analysis of interactions at a
model membrane surface. The methodology de-
scribed in this paper possesses some advantages
over methodologies using dextran matrix-based sen-
sor chips as the lipid monolayer is a more biospeci¢c
surface than the negatively charged dextran matrix.
Receptors in a lipid monolayer are mobile in the
plane of the lipid [31] and thus the model system is
well suited for the analysis of dimerising and co-op-
erative interactions.
Fig. 6. Repeated binding of chloroeremomycin to a N-docosa-
noyl-KAA/lipid monolayer. Forty successive injections of the
glycopeptide antibiotic chloroeremomycin (60 Wl, 10 WM) at a
£ow rate of 20 Wl/min to a N-docosanoyl-KAA/lipid monolayer,
followed by regeneration of the surface with hydrochloric acid
(10 Wl, 10 mM). (Traces superimposed and every ¢fth cycle of
binding and regeneration shown for clarity.)
Fig. 7. Correlation between surface/solution binding constants
of glycopeptide antibiotics to mucopeptide analogues and
MICs. Correlation between MIC values against Bacillus subtilis
and surface a⁄nity constants of glycopeptide antibiotics to the
lipid anchored mucopeptide analogue N-docosanoyl-KAA (b).
Solution a⁄nity constants [26] to the non-anchored analogue
N-acetyl-KAA (a) do not correlate with MIC values. BCE, bi-
phenylchloroeremomycin (LY307599); CE, chloroeremomycin
(LY264826); E, eremomycin; V, vancomycin; T, teicoplanin;
R, ristocetin A; TA3-1, teicoplanin aglycone A3-1.
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